Facial injectable market to reach US$ 9.07 billion by 2028

The global ‘facial injectables market’ size is expected to reach US$ 9.07 billion by 2028, exhibiting a CAGR of 9.6 per cent during the forecast period. The growing cognizance regarding aesthetic beauty can positively impact the global market growth, states Fortune Business Insights™ in a report titled “Facial Injectables Market, 2021-2028.” Including children and the elderly, aesthetic treatments have become more and more popular among people of all ages. Additionally, the increased safety features of these devices have led to their increased popularity. Therefore, boosting the facial injectables market share. According to the International Society of Aesthetic Plastic Surgery (ISAPS) figures, the total number of nonsurgical injectable treatments performed in India in 2019 was 113,616. Botulinum toxin and dermal fillers accounted for four-fifth of all treatments performed by facial surgeons in the United States in 2018, according to the American Academy of Face Plastic and Reconstructive Surgery’s (AAFPRS) annual study.